Abstract
Sixty patients with idiopathic cervical dystonia were treated a total of 240 times with botulinum toxin type A (BTA). Selected muscles were injected with BTA under electromyographic (EMG) guidance. The clinical effect was measured on the Tsui scale and a 10-point anchored visual analogue scale. A dosage of 150–300 mouse units was used in 77% of the treatments (mean 204 mouse units). Based on the Tsui scale, 45% of 240 treatments were still effective at the moment of reinjection (median improvement 2 points). Based on the 10-point anchored visual analogue scale, 73% of treatments were successful (median improvement 3 points). Forty-eight patients (80%) responded favourably to the treatment. Side-effects were mild and transient. Dysphagia occurred in 9% of treatments. Antibody production was investigated in 41 patients and was negative in all. A striking difference from previous reports is the lower dosage used in this study. The clinical response, however, was similar to that of other studies. We conclude that a dosage of 200–400 mouse units BTA (Dysport) may also be effective in the treatment of cervical dystonia, but with fewer side effects. EMG guidance and application of BTA into deep cervical muscles may further improve the clinical effect.
Similar content being viewed by others
References
Anderson TJ, Rivest J, Stell R, Steiger MJ, Cohen H, Thompson PD, Marsden CD (1992) Botulinum toxin treatment of spasmodic torticollis. JR Soc Med 85:524–529
Bertrand C, Molina-Negro P, Bourvier G, Gorczyca W (1987) Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation. Appl Neurophysiol 50: 319–323
Blackie JD, Lees AJ (1990) Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 53: 640–643
Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG (1992) Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 42:878–882
Gelb DJ, Lowenstein DH, Aminoff MJ (1989) Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 39: 80–84
Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, Aminoff MJ (1991) Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 29:370–376
Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E (1990) Double-blind, placebo-controlled trial of botulinum toxin injections for the treat ment of spasmodic torticollis. Neurology 40:1213–1218
Hambleton P, Cohen HE, Palmer BJ, Melling J (1992) Antitoxins and botulinum toxin treatment. BMJ 304: 959–960
Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 25:1186–1194
Jankovic J, Schwartz KS (1993) Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 43:834–836
Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41: 1088–1091
Koller W, Vetere-Overfield B, Gray C, Dubinsky R (1990) Failure of fixeddose, fixed muscle injections of botulinum toxin in torticollis. Clin Neuropharmacol 13:355–358
Lees AF, Turjanski N, Rivest J, Whurr R, Lorch M, Brookes G (1992) Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin. J Neurol 239:1–4
Lorentz IT, Subramaniam SS, Yiannikas C (1991) Treatment of spasmodic torticollis with botulinum toxin A: a double-blind study on twentythree patients. Mov Disord 6: 145–150
Moore AP, Blumhardt LD (1991) A double blind trial of botulinum toxin “A” in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 54: 813–816
Notermans S, Nagel J (1989) Assays for botulinum and tetanus toxins. In: Simpson LL (ed) Botulinum neurotoxin and tetanus toxin. Academic Press, San Diego, pp 319–331
Poewe W, Schelosky L, Kleedorfer B, Heinen F, Wagner M, Deuschl G (1992) Treatment of spasmodic torticollis with local injections of botulinum toxin. J Neurol 239:21–25
Stell R, Thompson PD, Marsden CD (1988) Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry 51:920–923
Tsui JK, Eisen A, Stoessl A, Calne DB (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 11: 245–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brans, J.W.M., de Boer, I.P., Aramideh, M. et al. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 242, 529–534 (1995). https://doi.org/10.1007/BF00867425
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00867425